GB202100996D0 - Ezrin-derived peptides and uses - Google Patents

Ezrin-derived peptides and uses

Info

Publication number
GB202100996D0
GB202100996D0 GBGB2100996.4A GB202100996A GB202100996D0 GB 202100996 D0 GB202100996 D0 GB 202100996D0 GB 202100996 A GB202100996 A GB 202100996A GB 202100996 D0 GB202100996 D0 GB 202100996D0
Authority
GB
United Kingdom
Prior art keywords
ezrin
derived peptides
peptides
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2100996.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Newalr&d Ltd
Original Assignee
Newalr&d Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newalr&d Ltd filed Critical Newalr&d Ltd
Priority to GBGB2100996.4A priority Critical patent/GB202100996D0/en
Publication of GB202100996D0 publication Critical patent/GB202100996D0/en
Ceased legal-status Critical Current

Links

GBGB2100996.4A 2021-01-25 2021-01-25 Ezrin-derived peptides and uses Ceased GB202100996D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2100996.4A GB202100996D0 (en) 2021-01-25 2021-01-25 Ezrin-derived peptides and uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2100996.4A GB202100996D0 (en) 2021-01-25 2021-01-25 Ezrin-derived peptides and uses

Publications (1)

Publication Number Publication Date
GB202100996D0 true GB202100996D0 (en) 2021-03-10

Family

ID=74859022

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2100996.4A Ceased GB202100996D0 (en) 2021-01-25 2021-01-25 Ezrin-derived peptides and uses

Country Status (1)

Country Link
GB (1) GB202100996D0 (en)

Similar Documents

Publication Publication Date Title
IL287781A (en) Clec12a-binding polypeptides and uses thereof
EP4165049A4 (en) Isotryptamine psychoplastogens and uses thereof
IL305809A (en) Tumor neoantigenic peptides and uses thereof
IL287782A (en) Cd33-binding polypeptides and uses thereof
EP4185599A4 (en) Stapled peptides and methods thereof
SG11202006669RA (en) Peptides and uses thereof
IL308790A (en) Stapled peptides and methods thereof
GB202109082D0 (en) Polypeptides and uses thereof
EP4172173A4 (en) Neutrophil-binding peptides
EP4168028A4 (en) Sars-cov-2 immunodominant peptides and uses thereof
GB2603645B (en) Polypeptides having anti-senescent effects and uses thereof
EP3947418C0 (en) Peptides and use thereof
EP4175970A4 (en) Peptides and uses thereof
IL311185A (en) Mog-binding proteins and uses thereof
GB201904720D0 (en) Peptide synthesis and modification
EP3996737A4 (en) Peptides and uses thereof
GB202002010D0 (en) Microtopographies and uses thereof
GB202100996D0 (en) Ezrin-derived peptides and uses
EP3984595A4 (en) Peptide and use thereof
GB202304356D0 (en) Peptides and uses thereof
IL284666A (en) Novel peptides and uses thereof
IL308123A (en) Mertk peptides and uses thereof
GB202018733D0 (en) Polypeptides and uses thereof
AU2021903722A0 (en) Peptides and Uses Thereof
AU2020904544A0 (en) Peptides and uses thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)